Stock Track | WuXi Biologics Soars 5.08% Intraday on Strong Annual Results and Positive Guidance

Stock Track05-04

WuXi Biologics' stock price soared 5.08% during intraday trading on Monday, reflecting strong investor confidence in the company's financial performance and future prospects.

The surge follows the company's recent disclosure of robust annual financial results, including full-year revenue growth of 16.7% to RMB 21.79 billion and a significant 30.9% increase in gross profit to RMB 10.02 billion. Net profit attributable to shareholders also rose by 17.9% to RMB 5.64 billion, while operating cash flow increased by 21.46%.

Market sentiment was further boosted by the company's positive forward guidance projecting revenue growth of 13%-17%, which enhanced earnings visibility and prompted investors to re-price the stock based on its favorable outlook.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1186912312?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-04 11:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1186912312","market":"nz","top_or_hot":-1,"title":"Stock Track | WuXi Biologics Soars 5.08% Intraday on Strong Annual Results and Positive Guidance","media":"Stock Track","content":"<p>WuXi Biologics' stock price soared 5.08% during intraday trading on Monday, reflecting strong investor confidence in the company's financial performance and future prospects.</p><p>The surge follows the company's recent disclosure of robust annual financial results, including full-year revenue growth of 16.7% to RMB 21.79 billion and a significant 30.9% increase in gross profit to RMB 10.02 billion. Net profit attributable to shareholders also rose by 17.9% to RMB 5.64 billion, while operating cash flow increased by 21.46%.</p><p>Market sentiment was further boosted by the company's positive forward guidance projecting revenue growth of 13%-17%, which enhanced earnings visibility and prompted investors to re-price the stock based on its favorable outlook.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | WuXi Biologics Soars 5.08% Intraday on Strong Annual Results and Positive Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | WuXi Biologics Soars 5.08% Intraday on Strong Annual Results and Positive Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-04 11:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>WuXi Biologics' stock price soared 5.08% during intraday trading on Monday, reflecting strong investor confidence in the company's financial performance and future prospects.</p><p>The surge follows the company's recent disclosure of robust annual financial results, including full-year revenue growth of 16.7% to RMB 21.79 billion and a significant 30.9% increase in gross profit to RMB 10.02 billion. Net profit attributable to shareholders also rose by 17.9% to RMB 5.64 billion, while operating cash flow increased by 21.46%.</p><p>Market sentiment was further boosted by the company's positive forward guidance projecting revenue growth of 13%-17%, which enhanced earnings visibility and prompted investors to re-price the stock based on its favorable outlook.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1186912312","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1186912312","pubTimestamp":1777864228,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"WuXi Biologics' stock price soared 5.08% during intraday trading on Monday, reflecting strong investor confidence in the company's financial performance and future prospects.The surge follows the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02269":"药明生物"},"translate_title":"个股赛道|药明生物盘中大涨5.08%全年业绩强劲指引利好","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"WuXi Biologics' stock price soared 5.08% during intraday trading on Monday, reflecting strong investor confidence in the company's financial performance and future prospects.The surge follows the company's recent disclosure of robust annual financial results, including full-year revenue growth of 16.7% to RMB 21.79 billion and a significant 30.9% increase in gross profit to RMB 10.02 billion. Net profit attributable to shareholders also rose by 17.9% to RMB 5.64 billion, while operating cash flow increased by 21.46%.Market sentiment was further boosted by the company's positive forward guidance projecting revenue growth of 13%-17%, which enhanced earnings visibility and prompted investors to re-price the stock based on its favorable outlook.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1186912312","isCrawlerRequest":true}